Clinical Trial Update: Introduction of Dispersible 3HP Formulations for TB Preventive Treatment in Children: a Multi-country Evaluation

View source ↗

Summary

A multi-country evaluation is introducing dispersible 3HP formulations for TB preventive treatment in children; the trial is currently NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• ISONIAZID (ISONIAZID)
• rifapentine (rifapentine)

Snippet

Sponsor: The Aurum Institute NPC | Conditions: TB - Tuberculosis, Household Contact | Status: NOT_YET_RECRUITING